3 Absurdly Cheap Growth Stocks to Load Up On Right Now
Novo Nordisk, PayPal, and Dell Technologies are modestly priced growth stocks with a lot of potential to rise higher.
They all trade at forward price-to-earnings multiples of 17 or less.
10 stocks we like better than Novo Nordisk ›
Buying stocks that are trading at cheap valuations can set you up for some big gains later on. And it can minimize the risk of a decline if the market starts to struggle.
Although many stocks look expensive today, there are three growth stocks which still seem absurdly cheap right now: Novo Nordisk (NYSE: NVO), PayPal (NASDAQ: PYPL), and Dell Technologies (NYSE: DELL). By investing in these companies, you can gain exposure to some top businesses, while also diversifying your portfolio. Here's a closer look at why each of these stocks can be a good long-term investment.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »
Novo Nordisk
Drugmaker Novo Nordisk is a terrific healthcare company to consider investing in. The market has been bearish on it over the past year, as recent results from clinical trials haven't met expectations; there are also new concerns that tariffs on pharmaceuticals may weigh down Novo Nordisk and similar stocks. But as concerning as these developments may be, they're also short-term in nature.
Novo Nordisk has been a growth-focused business for decades, and some solid products in its portfolio, including Wegovy and Ozempic, have enabled it to generate strong results in recent quarters and put it on track for even more growth in the future. Through the first three months of the year, the company grew its sales by 19% and its operating profit by 22%.
The company is a big-name player in the market for GLP-1 medications. And if you invest in it today, you can get it for a modest forward price-to-earnings (P/E) multiple of 17. That's based on analyst estimates, but it gives you a good idea of how cheap the stock is -- the average stock in the S&P 500 trades at a forward P/E of 24. With its encouraging growth prospects, Novo Nordisk could be a no-brainer buy at its current valuation.
PayPal
A fintech company that doesn't seem to get enough love these days is PayPal. There are certainly concerns that growing competition will chip away at its growth, but its payment platform remains a top choice for customers and vendors to rely on. Its share of the global payments market remains at 45%, making it the top option, despite a flurry of other ways to pay. The company also has its own stablecoin, PayPal USD, so it can potentially leverage opportunities in the crypto space.
Growth has been underwhelming of late, as sales through the first three months of the year totaled $7.8 billion, an increase of just 1% year over year. However, the economy is contending with rising costs and tariffs, so consumers scaling back on spending may have more to do with that slowdown than anything PayPal is doing.
It's far too early to count PayPal out as a top growth stock: There's still a lot of room for it to grow, especially with PayPal USD in the mix, and its Venmo app is rising in popularity as well. At a forward P/E of only 15, this is an even cheaper stock to own than Novo Nordisk.
Dell Technologies
Computer maker Dell Technologies isn't doing well with the consumer market this year, but sales of servers have been strong, especially as companies invest heavily in artificial intelligence (AI). For its current fiscal year (which ends in January), Dell projects that its AI server sales will top $15 billion, an increase from the $10 billion total in the previous year.
Dell is well positioned to take advantage of AI trends both in the business market and in the consumer market, through the sales of AI computers and servers. While sales of AI computers aren't taking off just yet, it may only be a matter of time before an upgrade cycle takes place, especially as consumers look to take advantage of next-gen computing capabilities.
In its most recent quarter, which ended on May 2, Dell's revenue rose by a modest 5% to $23.4 billion. But if not for a 19% decline in its consumer segment, those numbers would have been much better. Dell is a trusted computer manufacturer and it's doing well, even if its operations aren't firing on all cylinders.
At a forward P/E of less than 14, this is the cheapest stock on this list. With loads of potential in AI and other computing, Dell may be one of the better growth stocks to buy right now.
Should you invest $1,000 in Novo Nordisk right now?
Before you buy stock in Novo Nordisk, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,477!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,010,880!*
Now, it's worth noting Stock Advisor 's total average return is1,047% — a market-crushing outperformance compared to180%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of July 14, 2025
David Jagielski has positions in Novo Nordisk. The Motley Fool has positions in and recommends PayPal. The Motley Fool recommends Novo Nordisk and recommends the following options: long January 2027 $42.50 calls on PayPal and short June 2025 $77.50 calls on PayPal. The Motley Fool has a disclosure policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
18 minutes ago
- Globe and Mail
AECOM announces cash tender offer for any and all 5.125% Senior Notes due 2027
AECOM (NYSE: ACM) today announced that it has commenced a cash tender offer (the 'Tender Offer') for any and all of its $997,293,000 principal amount outstanding 5.125% Senior Notes due 2027 (the 'Notes'). A comprehensive description of the terms of the Tender Offer is included in AECOM's Offer to Purchase, dated July 15, 2025 (the 'Offer to Purchase'), and the related Notice of Guaranteed Delivery (the 'Notice of Guaranteed Delivery' and, together with the Offer to Purchase, the 'Offer Documents'). The following table summarizes the material pricing terms of the Tender Offer, which is being made upon, and is subject to, the terms and conditions set forth in the Offer Documents. CUSIP Nos Outstanding Principal Amount Title of Notes U.S. Treasury Reference Security Bloomberg Reference Page Fixed Spread 00774CAB3 00774CAA5 U0081CAA0 $997,293,000 5.125% Senior Notes due 2027 4.375% due December 15, 2026 PX4 50 bps The Tender Offer will expire at 5:00 p.m., New York City time, on July 21, 2025, unless extended or earlier terminated by AECOM (the 'Expiration Date'). No tenders submitted after the Expiration Date will be valid unless delivered pursuant to the guaranteed delivery procedures described in the Offer to Purchase at or prior to 5:00 p.m., New York City time, on July 23, 2025 (the 'Guaranteed Delivery Date'). Tenders of Notes may be withdrawn any time at or prior to 5:00 p.m., New York City time, on July 21, 2025, by following the procedures described in the Offer to Purchase. The consideration (the 'Total Consideration') offered for each $1,000 principal amount of the Notes validly tendered and not validly withdrawn and accepted for purchase pursuant to the Tender Offer will be determined in the manner described in the Offer to Purchase by reference to the fixed spread for the Notes specified in the table above plus the yield to December 15, 2026, based on the bid-side price of the Reference Security specified in the table above, as quoted on the Bloomberg Bond Trader PX4 page as of 11:00 a.m., New York City time, on July 21, 2025, unless extended or earlier terminated by AECOM. In addition to the Total Consideration, AECOM will also pay accrued and unpaid interest up to, but not including, the Initial Settlement Date (as defined below). The settlement date for Notes validly tendered and not validly withdrawn and accepted for purchase and delivered at or prior to the Expiration Date is expected to be July 22, 2025, the next business day after the Expiration Date (the 'Initial Settlement Date'). The settlement date for Notes delivered pursuant to the guaranteed delivery procedures described in the Offer to Purchase is expected to be July 24, 2025, the next business day after the Guaranteed Delivery Date (the 'Guaranteed Delivery Settlement Date'). For the avoidance of doubt, accrued interest will cease to accrue on the Initial Settlement Date for all Notes accepted in the Tender Offer, whether such Notes are purchased on the Initial Settlement Date or the Guaranteed Delivery Settlement Date. Holders must validly tender (and not validly withdraw) their Notes at or prior to the Expiration Date, or deliver a properly completed and duly executed Notice of Guaranteed Delivery for their Notes at or prior to the Expiration Date, and tender their Notes at or prior to the Guaranteed Delivery Date (as defined in the Offer to Purchase), in accordance with the instructions set forth in the Offer to Purchase, in order to be eligible to receive the Total Consideration. AECOM's obligation to accept for purchase and to pay for the Notes validly tendered and not validly withdrawn pursuant to the Tender Offer is subject to the satisfaction or waiver of certain conditions, which are more fully described in the Offer to Purchase, including, among others, AECOM having raised net proceeds from its concurrently commenced offering of $1,000,000,000 in aggregate principal amount of its senior unsecured notes due 2033 (the 'New Notes Offering'), which, together with cash on hand or other immediately available funds, are sufficient to fund the purchase of all Notes validly tendered and accepted for purchase in the Tender Offer (such condition, the 'Financing Condition'). In addition, concurrently with the pricing of the New Notes Offering, the Company intends to issue a conditional notice of redemption to the holders of the Notes to redeem any and all Notes that remain outstanding after completion of the Tender Offer at a make-whole redemption price based on a make-whole spread of 50 basis points over the yield of the Reference Security specified above, calculated pursuant to the applicable provisions of the indenture governing the Notes, plus accrued and unpaid interest to, but not including, the date of redemption. The date of redemption is expected to be August 14, 2025 (the 'Redemption Date'). The redemption of any and all Notes that remain outstanding after completion of the Tender Offer will be made in accordance with the provisions of the Indenture, and will be conditioned upon the satisfaction of the Financing Condition. The Tender Offer does not constitute an offer to sell or a solicitation of an offer to buy any securities or other financial instruments that may be issued or otherwise incurred in connection with the New Notes Offering. AECOM reserves the right, subject to applicable law, in its sole discretion, to: (i) waive any and all conditions to the Tender Offer at any time and from time to time; (ii) extend or terminate the Tender Offer; or (iii) otherwise amend the Tender Offer in any respect. AECOM is not soliciting consents from holders of securities in connection with the Tender Offer. AECOM has retained BofA Securities to act as exclusive Dealer Manager for the Tender Offer. D.F. King and Co., Inc. has been retained to serve as both the tender and information agent (the 'Tender and Information Agent') for the Tender Offer. For additional information regarding the terms of the Tender Offer, please contact: BofA Securities at debt_advisory@ (email), (888) 292-0070 (toll free) or (646) 743-2120 (collect). Requests for copies of the Offer to Purchase and other related materials should be directed to D.F. King and Co., Inc. at aecom@ (email), (888) 887-0082 (U.S. Toll Free), (212) 365-6884 (Banks and Brokers). Copies of the Offer to Purchase and Notice of Guaranteed Delivery are available at the following web address: This press release is for informational purposes only and is not an offer to purchase or a solicitation of an offer to sell with respect to any Notes nor is this announcement an offer to sell or a solicitation of an offer to purchase new debt securities, or a notice of redemption of the Notes. The Tender Offer is being made solely pursuant to the Offer Documents, which set forth the complete terms and conditions of the Tender Offer. The Tender Offer is not being made to, nor will AECOM accept tenders of Notes from, holders in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. None of AECOM, its affiliates, their respective board of directors, the Dealer Manager, the trustee of the Notes or the Tender and Information Agent makes any recommendation to any holder of Notes in connection with the Tender Offer. Holders must make their own decisions as to whether to tender their Notes and, if so, the principal amount of Notes to tender. About AECOM AECOM (NYSE: ACM) is the global infrastructure leader, committed to delivering a better world. As a trusted professional services firm powered by deep technical abilities, we solve our clients' complex challenges in water, environment, energy, transportation and buildings. Our teams partner with public- and private-sector clients to create innovative, sustainable and resilient solutions throughout the project lifecycle – from advisory, planning, design and engineering to program and construction management. AECOM is a Fortune 500 firm that had revenue of $16.1 billion in fiscal year 2024. Cautionary Note Regarding Forward-Looking Statements All statements in this press release other than statements of historical fact are 'forward-looking statements' for purposes of federal and state securities laws, including any statements of the plans, strategies and objectives for future operations, profitability, strategic value creation, capital allocation strategy including stock repurchases, risk profile and investment strategies, and any statements regarding future economic conditions or performance, and the expected financial and operational results of AECOM. Although AECOM believes that the expectations reflected in these forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of these forward-looking statements. Important factors that could cause AECOM's actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in these forward-looking statements include, but are not limited to, the following: AECOM's business is cyclical and vulnerable to economic downturns and client spending reductions; potential government shutdowns, changes in administration or other funding directives and circumstances that may cause governmental agencies to modify, curtail or terminate AECOM's contracts; government contracts are subject to audits and adjustments of contractual terms; long-term government contracts and subject to uncertainties related to government contract appropriations; losses under fixed-price contracts; limited control over operations that run through AECOM's joint venture entities; liability for misconduct by AECOM's employees or consultants; changes in government laws, regulations and policies, including failure to comply with laws or regulations applicable to AECOM's business; maintaining adequate surety and financial capacity; potential high leverage and inability to service AECOM's debt and guarantees; ability to continue payment of dividends; exposure to political and economic risks in different countries, including tariffs and trade policies, geopolitical events, and conflicts; inflation, currency exchange rates and interest rate fluctuations; changes in capital markets and stock market volatility; retaining and recruiting key technical and management personnel; legal claims and litigation; inadequate insurance coverage; environmental law compliance and inadequate nuclear indemnification; unexpected adjustments and cancellations related to AECOM's backlog; partners and third parties who may fail to satisfy their legal obligations; managing pension costs; AECOM Capital real estate development; cybersecurity issues, IT outages and data privacy; risks associated with the benefits and costs of the sale of AECOM's Management Services and self-perform at-risk civil infrastructure, power construction and oil and gas construction businesses, including the risk that any purchase adjustments from those transactions could be unfavorable and any future proceeds owed to us as part of the transactions could be lower than we expect; as well as other additional risks and factors that could cause actual results to differ materially from these forward-looking statements set forth in AECOM's reports filed with the Securities and Exchange Commission. Any forward-looking statements are made as of the date hereof. AECOM does not intend, and undertakes no obligation, to update any forward-looking statement.
CTV News
23 minutes ago
- CTV News
Lupita Nyong'o advocates for uterine health legislation after revealing fibroids diagnosis
Oscar-winning actress Lupita Nyong'o is sharing her experience of being diagnosed with uterine fibroids, using the opportunity as a call to action on Capitol Hill. (Michael Tran/AFP/Getty Images via CNN Newsource) Oscar-winning actress Lupita Nyong'o is sharing about her experience of being diagnosed with uterine fibroids, using the opportunity as a call to action on Capitol Hill. Nyong'o wrote on her Instagram page Tuesday that in 2014, the same year that she won an Oscar for '12 Years a Slave,' she 'discovered' that she had 30 uterine fibroids and underwent surgery to remove them. 'I started talking about my experience privately, and I realized so many women are going through this,' she wrote. 'We're struggling alone with something that affects most of us. No more suffering in silence!' Uterine fibroids are non-cancerous muscular tumors that grow in the wall of the uterus, according to the Office of Women's Health. Symptoms can be severe and may include heavy menstrual bleeding, painful periods and stomach pain. According to a report by the National Center for Biotechnology Information, Black women are three times more likely to develop fibroids than white women. Nyong'o wrote in her post that in light of July being Fibroid Awareness Month, she wanted to share her experience, saying she hopes it will 'resonate with anyone else who has ever felt dismissed, confused or alone.' Also on Tuesday, the 'Quiet Place: Day One' star appeared on Capitol Hill with Congresswoman Yvette D. Clarke to help introduce a legislative bill package that they hope will advance uterine health initiatives, according to a news release. The four bills they introduced 'would expand research funding, increase early detection and interventions for uterine fibroids, study the causes of uterine cancer, and increase public awareness,' Nyong'o wrote in the caption of her Instagram post. 'In 2014 at the age of 31, I received my uterine fibroid diagnosis and was offered only two options: invasive surgery to remove them or live with the pain,' she said in a statement. 'I envision a different future: one with early education for teenagers, better prevention and screening protocols, robust research, and less invasive treatments for uterine fibroids.' Nyong'o also announced that she is launching the FWH x Lupita Nyong'o Uterine Fibroid Grant in partnership with the Foundation for Women's Health. The grant will fund medical research of uterine fibroids, according to the foundation's official website. 'I hope to seek answers for the far too many women dealing with uterine fibroids,' Nyong'o said Tuesday. 'We must reject the normalization of female pain.'
Globe and Mail
23 minutes ago
- Globe and Mail
Aura Announces Pricing of U.S. Initial Public Offering
ROAD TOWN, British Virgin Islands, July 15, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) ('Aura' or the 'Company') today announced that it has priced its U.S. initial public offering of 8,100,510 common shares at a public offering price of US$24.25 per common share. The principal purposes of this offering are to transfer Aura's principal listing venue to a stock exchange in the United States equity market, which the Company believes will increase the liquidity of its common shares, as well as strengthen and diversify its shareholder base through broader access to global capital markets. In addition to the listing, Aura intends to use the net proceeds from the offering to continue strengthening its business, which includes (A) funding the component of the upfront cash payment for the acquisition of Mineração Serra Grande S.A. ('MSG'), upon and subject to closing, and any potential incremental capital expenditures required at MSG, as well as (B) providing incremental liquidity and financial flexibility to support the execution of its current strategic growth initiatives, including, but not limited to: (i) the potential advancement of its current development projects, such as Era Dorada and Matupá; and (ii) exploration initiatives to expand mineral reserves and resources of its portfolio, and (C) the remainder for general corporate purposes. The Company's common shares have been approved for listing on the Nasdaq Global Select Market and will start trading on July 16, 2025 under the ticker symbol 'AUGO'. The offering is expected to settle on or about July 17, 2025, subject to customary closing conditions. In connection with the offering, Aura has granted to the underwriters a 30-day option to purchase up to an additional 1,215,077 common shares at the public offering price, less underwriting discounts and commissions. BofA Securities and Goldman Sachs & Co. LLC are acting as Global Coordinators, BTG Pactual and Itaú BBA are acting as Joint Bookrunners and Bradesco BBI, National Bank of Canada Financial Markets, RBC Capital Markets and Scotiabank are acting as Co-Managers of the offering. The offering is being made in the United States only by means of a prospectus. Copies of the prospectus related to the offering may be obtained, when available, from BofA Securities, 201 North Tryon Street, Charlotte, NC 28255-0001, Attn: Prospectus Department. A registration statement relating to this offering has been filed with, and declared effective by, the U.S. Securities and Exchange Commission. This communication to the market shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. Shareholders' preemptive rights in new shares issuances, such as the offering, are expressly excluded pursuant to the Company's memorandum and articles of association. There will be no pre-emptive right for the Brazilian Depositary Receipts holders in connection with the public offering. The offering will not be carried out by any means that would constitute a public offering in Brazil under Law No. 6,385, dated December 7, 1976, as amended, and under Brazilian Securities Commission ('CVM') Resolution (Resolução) No. 160, dated July 13, 2022, as amended ('CVM Resolution 160'). The offering has not been and will not be registered with the CVM in Brazil. The common shares may not be offered or sold in Brazil except in circumstances which do not constitute a public offering for distribution under Brazilian securities laws and regulations. No prospectus has been filed with any securities commission or similar regulatory authority in Canada in connection with this offering. The offering will not be made available to the public in Canada. Any offering into Canada will be made exclusively by way of a private placement pursuant to an exemption from the prospectus requirements of applicable Canadian provincial and territorial securities laws and is subject to receipt of approval from the TSX. In Canada, only investors purchasing, or deemed to be purchasing, as principal that are accredited investors (as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario)) and are permitted clients (as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations) are eligible to invest. About Aura 360° Mining Aura is focused on mining in complete terms – thinking holistically about how its business impacts and benefits every one of our stakeholders: our company, our shareholders, our employees, and the countries and communities we serve. We call this 360° Mining. Aura is a company focused on the development and operation of gold and base metal projects in the Americas. The Company's five operating assets include the Minosa gold mine in Honduras; the Almas, Apoena, and Borborema gold mines in Brazil; and the Aranzazu copper, gold, and silver mine in Mexico. Additionally, the Company owns Era Dorada, a gold project in Guatemala; Tolda Fria, a gold project in Colombia; and three projects in Brazil: Matupá, which is under development; São Francisco, which is in care and maintenance; and the Carajás copper project in the Carajás region, in the exploration phase. Caution Regarding Forward-Looking Information and Statements This press release includes certain statements and information that may constitute "forward-looking information" within the meaning of applicable Canadian securities laws and/or "forward-looking statements" within the meaning of applicable United States securities laws (collectively, "forward-looking statements"). Forward-looking statements relate to future events or future performance and reflect the Company's current estimates, predictions, expectations or beliefs regarding future events and include, without limitation, statements with respect to: statements relating to the public offering of the Company's common shares; the expected timing of the public offering; the registration and listing of the Company's common shares in the United States; the means by which the offering will be made; and the Company's business strategies. Often, but not always, forward-looking statements may be identified by the use of words such as "expects", "anticipates", "plans", "projects", "estimates", "assumes", "intends", "strategy", "goals", "objectives" or variations thereof or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved, or the negative of any of these terms and similar expressions. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements in this press release are based upon, without limitation, the following estimates and assumptions: the Company carrying out its public offering; the Company successfully completing the SEC review process; obtaining requisite regulatory approvals; and general business, economic and market conditions. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Important factors that may cause actual results to vary, include, without limitation, that the Company may not carry out its public offering or complete the SEC review process. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement or forward-looking information, except in accordance with applicable securities laws.
